This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bethphagen Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Pyoung Oh Yoon: Innovator in Cardiac Health
Introduction
Pyoung Oh Yoon is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of cardiac health through his innovative research and patents. His work focuses on developing pharmaceutical compositions aimed at treating heart failure.
Latest Patents
Pyoung Oh Yoon holds a patent for a pharmaceutical composition comprising CCN5 for reducing cardiac fibrosis in subjects in need thereof. This invention relates to a method for preventing or treating heart failure. The pharmaceutical composition includes CCN5 or CCN2-CT protein, or a genetic carrier with a nucleotide sequence encoding these proteins. It exhibits remarkable efficacy in preventing or treating heart failure, even without surgical interventions such as heart transplants.
Career Highlights
Throughout his career, Pyoung Oh Yoon has worked with various organizations, including Bethphagen Inc. and the Gwangju Institute of Science and Technology. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Pyoung Oh Yoon has collaborated with notable colleagues, including Woo Jin Park and Dong Kwon Yang. Their joint efforts have furthered research in the field of cardiac health and innovation.
Conclusion
Pyoung Oh Yoon's contributions to cardiac health through his innovative patent demonstrate his commitment to improving medical treatments for heart failure. His work continues to inspire advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile